VitalHub Announces Multi-Year Licensing Agreement With Wrightington Wigan and Leigh Teaching Hospitals NHS Foundation Trust
TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a multi-year licensing agreement with Wrightington Wigan and Leigh Teaching Hospitals NHS Foundation Trust (the “Trust or “WWL”) for the use of subsidiary Intouch with Health’s (“Intouch”) patient flow solutions.
The Company has completed a multi-year licensing agreement with WWL, to implement digitalized pre-screening processes and patient flow management solutions.
Notably, the Trust is responsible for a host of specialist care services on a regional, national, and international basis, providing a broad array of services across its various sites, ranging from accident and emergency care to chronic disease management, specialist cancer and surgical specialties, as well as providing care across its community clinics. Additionally, the Trust directly serves a local population of 326,000 across the Northwest of England. The Trust comprises three main hospital sites, Royal Albert Edward Infirmary, Wrightington Hospital, and Leigh Infirmary, and thirty-three clinics.
Responding to the large patient population in need of face-to-face appointments that cannot afford to visit hospitals or medical centers due to their high-risk association with COVID-19, a solution was required to ensure patients can safely access and receive the care they need. Intouch’s mobile check-in solution will provide the first stage solution toward addressing the Trust’s needs. The current agreement will extend across five of the Trust’s sites, and include the use of proprietary Flow Manager, Room and Resource Manager, Mobile Appointment Manager, and HL7 Channels solutions.
“We are delighted to support Wrightington Wigan and Leigh Teaching Hospitals NHS Foundation Trust in helping resume in-person patient services,” said Dan Matlow, CEO of VitalHub Corp. “We see significant opportunity to continue to deepen our support of these solutions within the Trust, and across the NHS, as we work to provide critical patient flow and operational visibility data to health systems.”
ABOUT WRIGHTINGTON WIGAN AND LEIGH TEACHING HOSPITALS NHS FOUNDATION TRUST
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust (WWL) is a medium sized acute and community NHS Foundation Trust in the Northwest of England, within the Greater Manchester footprint. It serves a local population of 326,000 and provides specialist services to a much wider regional, national and international catchment area. The services include specialist Breast Cancer services (Thomas Lineacre Centre) and (through Wrightington Hospital) hip replacement surgery. Sir John Charnley was the clinical consultant who pioneered hip replacement surgery and his name remains internationally renowned. WWL provides acute clinical services from five main sites: Royal Albert Edward Infirmary, Wrightington Hospital, Leigh Infirmary, Thomas Linacre Centre and Boston House. Community services are provided from a range of locations across the borough.
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience & optimize outcomes.
VitalHub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 275+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol “VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.